MedPacto

Basic profile, industry tags, contact details, and company identifiers in one place.

Korean legal name: 메드팩토
KOSDAQ (235980) Bio/Pharmaceutical Professional Services Tumor microenvironment targeted therapy Osteosarcoma treatment drug TGF-beta signaling inhibition technology MP010 national new drug development project R&D +11
📍 Seoul
Representative
Ki***********
Established
2013년 (13 years since establishment)
Employees
정보없음
Address
Borum Building, 92 Myeongdal-ro, Seocho-gu, Seoul...
Phone
-
Capital
정보없음

What does MedPacto do?

A plain-language overview of what this company does.

A biotech company founded in 2013 that focuses on developing TGF-beta signaling inhibition technology for cancer treatment and targeted therapies for the tumor microenvironment (TME). It concentrates on combination therapies intended to improve treatment outcomes for cancer patients who do not respond well to existing anticancer or immuno-oncology drugs.

MedPacto at a glance

A short summary of the company, industry, business areas, and related records.

MedPacto is a biotech company focused on cancer therapeutics. It develops TGF-beta pathway inhibitors and targeted therapies for the tumor microenvironment, with an emphasis on combination treatments.

  • Industry: Professional Services
  • Related business areas: Tumor microenvironment targeted therapy, Osteosarcoma treatment drug, TGF-beta signaling inhibition technology, MP010 national new drug development project
  • Products and services: Vactosertib (TGF-beta signaling inhibitor), MP010 (immuno-oncology drug), Osteosarcoma treatment drug, Metastatic colorectal cancer treatment drug
  • Related keywords: treatment, anticancer, immunotherapy, signal, drug development
Reference informationMay differ from current company information.

Business details

Industry, products, services, and related business signals that help explain this company.

MedPacto products and services

Products and services mentioned in company information.

4
Vactosertib (TGF-beta signaling inhibitor)
MP010 (immuno-oncology drug)
Osteosarcoma treatment drug
Metastatic colorectal cancer treatment drug

Relationships and records

Review related companies, companies to compare, and business references when needed.

Companies to review together with MedPacto

Companies found in related business contexts.

Example Information Systems Co., Ltd.

Computer system design and consulting

Reference company for public infrastructure projects

Example Solutions Co., Ltd.

Application software development and supply

Reference company for e-government and data analytics

Review companies found in related business contexts.

Reference and discovery

Continue with related links, information basis, and more company search.

Information basis

See how the information on this page is organized.

This page organizes reference information from the G2BMarket company database and related business signals. Details may differ from the latest real-world status, so please use the correction or removal request if you find an error or exposure issue.

Basic company information and industry
Business description and related areas
Related business references
Related company and business discovery

Data usage notice

All data on this page is processed information and is protected as copyrighted/database content. Unauthorized collection or resale is prohibited. View guidelines

Data is organized through G2BMarket collection and processing based on public data and external sources. It may differ from current real-world status. Use Edit/Hide if you find an error or exposure issue.

@Team G2BMarket    |    
break8524@gmail.com |     Terms of Use    |    Privacy Policy

You can review the data usage guidelines from the "View guidelines" button on detail pages at any time.

All data is organized through internal collection and processing based on public data and external sources, and may differ from current real-world status. Errors or exposure issues can be submitted through the edit/hide process on detail pages.

© 2026 G2BMarket. All data is organized and processed according to internal standards based on public data and external sources. Unauthorized collection, storage, reprocessing, or redistribution is prohibited. Please review the guidelines on each detail page for more information.